New weight loss drugs could be developed much faster if Roche gets its way
Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop new drugs, including its slate of experimental weight loss and diabetes medications.
Weight loss drugs are rising in popularity, but they do carry risks
We know there are several physical risks associated with the drugs, but some are now beginning to question whether there are mental risks.
Popular Weight Loss Drugs Now for Patients With Cancer?
Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes. But data on the practice remain limited.
New weight-loss drug shows promise in reducing diabetes risk
Researchers from the University of Liverpool have found that the weight-loss drug tirzepatide could significantly reduce the risk of developing type 2 diabetes (T2D). This finding offers new hope in the battle against obesity and diabetes,
New Oral Weight Loss Drug Cuts Body Weight by 13% in Just 12 Weeks
Amycretin, an oral weight loss drug, led to up to 13% body weight reduction in three months, showing potential for continued weight loss. While well-tolerated, further long-term studies are needed to evaluate its safety and efficacy.
Opinion
Jarvis: High weight loss drug costs hurt
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic
While brand-name weight loss drugs are in short supply, a market for alternatives thrives
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
Eat Like This to Avoid Diabetes, Lose Weight, Study Suggests
Scientists found that eating within an 8 to 10 hour window was better for blood sugar control and fat loss than eating ...
Weight loss drugs like Ozempic and Wegovy are tremendously popular and effective. Patients should also be careful in using them
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
Popular diabetes and weight-loss drug associated with lower opioid overdose risk
Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United ...
Medical News Today3d
Weight-loss surgery may preserve kidney health more effectively than GLP-1 drugs
People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...
NBC News6d
Maker of popular diabetes and weight-loss drugs grilled about high cost in the U.S.
The CEO of Novo Nordisk was questioned about the high cost in the U.S. of Wegovy and Ozempic, the wildly popular diabetes ...